Page last updated: 2024-10-23

bendroflumethiazide and Breast Neoplasms

bendroflumethiazide has been researched along with Breast Neoplasms in 1 studies

Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"Bendroflumethiazide was associated with increased breast cancer risk (OR: 1."3.88A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties. ( Busby, J; Cardwell, CR; Liberante, F; Mills, K; Murray, L; Zhang, SD, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busby, J1
Murray, L1
Mills, K1
Zhang, SD1
Liberante, F1
Cardwell, CR1

Other Studies

1 other study available for bendroflumethiazide and Breast Neoplasms

ArticleYear
A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties.
    Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Bendroflumethiazide; Breast Neoplasms; Case-Control Studies; Confoun

2018